Carregant...
IMMU-60. PD-L1 EXPRESSION ASSOCIATED WITH GLIOMA MOLECULAR SUBTYPES: CLINICAL IMPLICATIONS
The development of immune checkpoint blockade therapy has ushered in a new era of cancer treatment. The use of inhibitors targeting programmed cell death protein 1 (PD1) and/or its ligand 1 (PD-L1) has shown activity in several cancer types and is currently being tested in glioma clinical trials. Pr...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692996/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.518 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|